Evidence map›Paper›PMID 32413093›Full record

ArticlePLoS pathogens2020

Toxoplasma gondii dense granule protein GRA24 drives MyD88-independent p38 MAPK activation, IL-12 production and induction of protective immunity.

Heather L Mercer, Lindsay M Snyder, Claire M Doherty, Barbara A Fox, David J Bzik, Eric Y Denkers

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
5.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 46 citations in OpenAlex.

  1. Virulence · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. DGPD: a knowledge database of dense granule proteins of the Apicomplexa.Database : the journal of biological databases and curation · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Synergy betweenJournal for immunotherapy of cancer · 2021
    Article
  15. Review
  16. Article
  17. Secreted Effectors Modulating Immune Responses toLife (Basel, Switzerland) · 2021
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Heather L MercerCenter for Evolutionary and Theoretical Immunology and Department of Biology, University of New Mexico, Albuquerque, New Mexico, United States of America.ORCID 0000-0002-8028-5514
Lindsay M SnyderCenter for Evolutionary and Theoretical Immunology and Department of Biology, University of New Mexico, Albuquerque, New Mexico, United States of America.
Claire M DohertyCenter for Evolutionary and Theoretical Immunology and Department of Biology, University of New Mexico, Albuquerque, New Mexico, United States of America.ORCID 0000-0002-2583-3258
Barbara A FoxDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, United States of America.
David J BzikDepartment of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, United States of America.
Eric Y DenkersCenter for Evolutionary and Theoretical Immunology and Department of Biology, University of New Mexico, Albuquerque, New Mexico, United States of America.ORCID 0000-0001-9020-3327
University of New Mexico · USDartmouth College · US

Funding

Pilot Project ProgramP30GM110907 · NIGMS · UNIVERSITY OF NEW MEXICO · PI MILLER, ROBERT D · 2014 to 2018
$5.4M
Unravelling MyD88-dependent and independent mucosal immunity to ToxoplasmaR01AI139628 · NIAID · UNIVERSITY OF NEW MEXICO · PI ERIC Y DENKERS · 2018 to 2026
$3.6M
Novel virulence function in Toxoplasma chronic infectionR21AI131630 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2018 to 2019
$446k
Genetic models for latent Toxoplasma gondii infectionR21AI137118 · NIAID · DARTMOUTH COLLEGE · PI BZIK, DAVID J · 2018 to 2019
$446k
Basis of MyD88-independent Th1 immunity during Toxoplasma infectionR21AI119708 · NIAID · UNIVERSITY OF NEW MEXICO · PI DENKERS, ERIC Y · 2016 to 2017
$417k
NIAID NIH HHS R01 AI139628NIAID NIH HHS R21 AI119708NIAID NIH HHS R21 AI131630NIAID NIH HHS R21 AI137118NIGMS NIH HHS P30 GM110907
6 · The paper itself

Abstract

The apicomplexan Toxoplasma gondii induces strong protective immunity dependent upon recognition by Toll-like receptors (TLR)11 and 12 operating in conjunction with MyD88 in the murine host. However, TLR11 and 12 proteins are not present in humans, inspiring us to investigate MyD88-independent pathways of resistance. Using bicistronic IL-12-YFP reporter mice on MyD88+/+ and MyD88-/- genetic backgrounds, we show that CD11c+MHCII+F4/80- dendritic cells, F4/80+ macrophages, and Ly6G+ neutrophils were the dominant cellular sources of IL-12 in both wild type and MyD88 deficient mice after parasite challenge. Parasite dense granule protein GRA24 induces p38 MAPK activation and subsequent IL-12 production in host macrophages. We show that Toxoplasma triggers an early and late p38 MAPK phosphorylation response in MyD88+/+ and MyD88-/- bone marrow-derived macrophages. Using the uracil auxotrophic Type I T. gondii strain cps1-1, we demonstrate that the late response does not require active parasite proliferation, but strictly depends upon GRA24. By i. p. inoculation with cps1-1 and cps1-1:Δgra24, we identified unique subsets of chemokines and cytokines that were up and downregulated by GRA24. Finally, we demonstrate that cps1-1 triggers a strong host-protective GRA24-dependent Th1 response in the absence of MyD88. Our data identify GRA24 as a major mediator of p38 MAPK activation, IL-12 induction and protective immunity that operates independently of the TLR/MyD88 cascade.

Indexed as

AnimalsEnzyme ActivationInterleukin-12MacrophagesMAP Kinase Signaling SystemMiceMice, KnockoutMyeloid Differentiation Factor 88p38 Mitogen-Activated Protein KinasesProtozoan ProteinsToxoplasmaToxoplasmosisInterleukin-12Myd88 protein, mouseMyeloid Differentiation Factor 88p38 Mitogen-Activated Protein KinasesProtozoan Proteins

Identifiers

PMID32413093
PMCPMC7255617
OpenAlexW3024550351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.